4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001209191-22-061755
Chief Financial Officer sold 2,089 shares at $3.25 ($6,789)
- Chief Financial Officer acquired 6,041 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2022-12-15 | Option exercise | +6,041 | 69,512 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2022-12-15 | Sale | −2,089 | $3.25 | $6,789 | 67,423 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2022-12-15 | Option exercise · Restricted Stock Unit | −6,041 | 12,084 | D | ||
| Open-market sales · 2,089 sh · avg $3.25 · $6,789 | |||||||
Loading xslF345X03/doc4.xml…